Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation

S Shukla, BL Tekwani - Frontiers in pharmacology, 2020 - frontiersin.org
Histone deacetylases (HADC) are the enzymes that remove acetyl group from lysine residue
of histones and non-histone proteins and regulate the process of transcription by binding to …

[HTML][HTML] Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective

V Kumar, S Kundu, A Singh, S Singh - Current neuropharmacology, 2022 - ncbi.nlm.nih.gov
Neurodegenerative diseases are a group of pathological conditions that cause motor inc-
ordination (jerking movements), cognitive and memory impairments result from …

The epigenetics of aging and neurodegeneration

R Lardenoije, A Iatrou, G Kenis, K Kompotis… - Progress in …, 2015 - Elsevier
Epigenetics is a quickly growing field encompassing mechanisms regulating gene
expression that do not involve changes in the genotype. Epigenetics is of increasing …

Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against …

L Marek, A Hamacher, FK Hansen, K Kuna… - Journal of medicinal …, 2013 - ACS Publications
The synthesis and biological evaluation of new potent hydroxamate-based HDAC inhibitors
with a novel alkoxyamide connecting unit linker region are described. Biological evaluation …

Class II a HDAC s–new insights into their functions in physiology and pathology

M Parra - The FEBS journal, 2015 - Wiley Online Library
HDAC 4, 5, 7 and 9 constitute the class II a histone deacetylases (HDAC s) within the large
family of protein deacetylases. Class II a HDAC s have unique features that distinguish them …

Histone deacetylases in memory and cognition

J Penney, LH Tsai - Science signaling, 2014 - science.org
Over the past 30 years, lysine acetylation of histone and nonhistone proteins has become
established as a key modulator of gene expression regulating numerous aspects of cell …

Epigenetic alterations in Alzheimer's disease

JV Sanchez-Mut, J Gräff - Frontiers in behavioral neuroscience, 2015 - frontiersin.org
Alzheimer's disease (AD) is the major cause of dementia in Western societies. It progresses
asymptomatically during decades before being belatedly diagnosed when therapeutic …

Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester

SA Hashim, TB VanItallie - Journal of lipid research, 2014 - ASBMB
Ketone bodies (KBs), acetoacetate and β-hydroxybutyrate (βHB), were considered harmful
metabolic by-products when discovered in the mid-19th century in the urine of patients with …

[HTML][HTML] Histone deacetylases (HDACs) and brain function

CH Volmar, C Wahlestedt - Neuroepigenetics, 2015 - Elsevier
Modulation of gene expression is a constant and necessary event for mammalian brain
function. An important way of regulating gene expression is through the remodeling of …

The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer's disease

S Yang, R Zhang, G Wang, Y Zhang - Translational neurodegeneration, 2017 - Springer
Alzheimer's disease (AD) is a chronic neurodegenerative disease, which is associated with
learning and memory impairment in the elderly. Recent studies have found that treating AD …